베인은 홈페이지 기능 및 성능 개선을 위해 쿠키를 사용합니다. 이와 관련된 더 많은 정보는 개인정보 메뉴에서 확인하실 수 있습니다. 이 웹사이트를 계속 사용하시면 쿠키 사용에 동의하신 것으로 간주됩니다. 

스냅차트

Covid-19 Will Have Long-Lasting Effects on European Healthcare

Pharma executives see rapid changes ahead, including a sharp rise in telehealth and reconfiguration of pharma supply chains.

스냅차트

Covid-19 Will Have Long-Lasting Effects on European Healthcare
en

Bain research shows Covid-19 is likely to prompt long-term shifts in patient behavior, hospital workflows, pharma sales models and supply-chain tracking. The pandemic already has sharply increased the number of first-time users of telehealth and accelerated the growth of online pharmacy channels. Hospitals are implementing new triage methods for diagnosis and treatment and seeking to ensure local sources for vital items to back up the existing supply chain. 

As the healthcare landscape evolves, pharma companies plan to change their go-to-market models and reconfigure supply chains to improve product tracking. To adapt to the speed and breadth of change, leaders are increasing investment in digital capabilities. As the healthcare industry evolves, healthcare profit pools will shift, creating new winners and losers.

Related Webinar

Implications for Healthcare Private Equity Investors in Europe

Leaders with Bain's Private Equity and Healthcare practices explain how the Covid-19 pandemic is affecting European private equity investors in the healthcare sector and what companies are doing to recover

Related Insights

Coronavirus

As the global pandemic deepens and the human cost of Covid-19 rises, the novel coronavirus outbreak is sending shocks through the world economy. But across industries, companies can take action now to protect their employees and customers and minimize the economic damage.

태그

베인에 궁금하신 점이 있으신가요?

베인은 글로벌 리더들이 중요한 이슈를 해결하고 기회를 놓치지 않도록 지원합니다. 고객사와 협력하여 지속되는 변화와 성과를 창출합니다.